Bayer's Bond Sale Targets Monsanto Acquisition Funds

The video discusses a unique financial offering that was not listed as a 144A but was heavily marketed to institutional investors, particularly insurance companies. The offering, expected to be around $15 billion, was not eligible for indexed bonds, which limited some index access. The roadshow for this offering was extensive, and the pricing ended up at 185 over Treasurys, indicating a strong investor appetite, especially from insurance companies and pension plans, for longer-dated bonds like the 30-year and 20-year parts.

What was the expected size of the bond offering discussed in the text?

What challenges do insurance companies face regarding ETF investments as mentioned in the text?